Beloved,
I wish above all things that thou mayest...be in health..
3 John 1:2
So "Orange Man" was right this whole time?
"An observational multi-center study, coordinated by the I.R.C.C.S. Neuromed, with the participation of 33 Italian hospitals, shows that the risk of death is 30% lower for coronavirus patients treated with hydroxychloroquine.
An Italian observational study contributes to the ongoing debate regarding the use of hydroxychloroquine in the current pandemic. The research, conducted on 3,451 patients treated in 33 hospitals throughout the Italian territory (list of participating centers attached), shows that the use of this drug reduces by 30% the risk of death in hospitalized patients affected by Covid-19.
Published in the European Journal of Internal Medicine, the study was coordinated by the Department of Epidemiology and Prevention of the I.R.C.C.S. Neuromed, Pozzilli, in collaboration with Mediterranea Cardiocentro, Naples, and the University of
Pisa, with the participation of 33 hospitals forming the CORIST collaboration (COvid-19 RISk and Treatments).
“We observed — explains Augusto Di Castelnuovo, epidemiologist at the Neuromed Department of Epidemiology and Prevention, currently at Mediterranea Cardiocentro in Naples — that patients treated with hydroxychloroquine had a 30% lower in-hospital mortality rate compared to those not receiving this treatment.
Our data were subjected to extremely rigorous statistical analysis, taking into account all the variables and possible confounding factors that could come into play. The drug efficacy was evaluated in various subgroups of patients. The positive results of hydroxychloroquine treatment remained unchanged, especially in those patients showing a more evident inflammatory state at the moment of admission to hospital.”
“In past months — comments Giovanni de Gaetano, President of Neuromed — the World Health Organization recommended a stop to the use of hydroxychloroquine on the basis of an international observational study, subsequently retracted.
Now the new data from the CORIST study, resulting from a ‘real life’ national collaboration, might help Health Authorities better clarify the role of this drug in the treatment of COVID-19 patients.”
SciTechDaily